198 related articles for article (PubMed ID: 34679035)
1. Influence of Morphometry on Echocardiographic Measurements in Cavalier King Charles Spaniels: An Inverse Probability Weighting Analysis.
Bagardi M; Ghilardi S; Locatelli C; Bionda A; Polli M; Bussadori CM; Colombo FM; Pazzagli L; Brambilla PG
Vet Sci; 2021 Sep; 8(10):. PubMed ID: 34679035
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic Evaluation of the Mitral Valve in Cavalier King Charles Spaniels.
Bagardi M; Bionda A; Locatelli C; Cortellari M; Frattini S; Negro A; Crepaldi P; Brambilla PG
Animals (Basel); 2020 Aug; 10(9):. PubMed ID: 32825079
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
Sudunagunta S; Green D; Christley R; Dukes-McEwan J
J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
[TBL] [Abstract][Full Text] [Related]
4. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
Ghilardi S; Lecchi C; Bagardi M; Romito G; Colombo FM; Polli M; Franco C; Brambilla PG
PLoS One; 2022; 17(12):e0274724. PubMed ID: 36574372
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
Prieto Ramos J; Corda A; Swift S; Saderi L; De La Fuente Oliver G; Corcoran B; Summers KM; French AT
Animals (Basel); 2021 Mar; 11(4):. PubMed ID: 33800666
[TBL] [Abstract][Full Text] [Related]
6. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
[TBL] [Abstract][Full Text] [Related]
7. Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
Bagardi M; Ghilardi S; Zamarian V; Ceciliani F; Brambilla PG; Lecchi C
PLoS One; 2022; 17(7):e0266208. PubMed ID: 35816500
[TBL] [Abstract][Full Text] [Related]
8. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
Wesselowski S; Gordon SG; Fries R; Saunders AB; Sykes KT; Vitt J; Boutet B; Häggström J; Kadotani S; Stack J; Barnett BG
J Vet Cardiol; 2023 Dec; 50():1-16. PubMed ID: 37913604
[TBL] [Abstract][Full Text] [Related]
9. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
[TBL] [Abstract][Full Text] [Related]
10. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
12. Relationship between syringomyelia and myxomatous mitral valve disease in Cavalier King Charles spaniels.
Bach MBT; Stougaard CL; Thøfner MS; Reimann MJ; Westrup U; Koch J; Fredholm M; Martinussen T; Berendt M; Olsen LH
J Vet Intern Med; 2024; 38(2):904-912. PubMed ID: 38391152
[TBL] [Abstract][Full Text] [Related]
13. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic measurement of the mitral valve in normal Cavalier King Charles spaniels: repeatability, optimal future study methods, and preliminary reference intervals.
Wesselowski S; Saunders AB; Werre S; Gordon SG
J Vet Cardiol; 2022 Oct; 43():81-92. PubMed ID: 36099705
[TBL] [Abstract][Full Text] [Related]
15. Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.
Birkegård AC; Reimann MJ; Martinussen T; Häggström J; Pedersen HD; Olsen LH
J Vet Intern Med; 2016; 30(1):63-8. PubMed ID: 26578464
[TBL] [Abstract][Full Text] [Related]
16. Depleted Myocardial Coenzyme Q10 in Cavalier King Charles Spaniels with Congestive Heart Failure Due to Myxomatous Mitral Valve Disease.
Christiansen LB; Reimann MJ; Schou-Pedersen AMV; Larsen S; Lykkesfeldt J; Olsen LH
Antioxidants (Basel); 2021 Jan; 10(2):. PubMed ID: 33499156
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration.
Meurs KM; Friedenberg SG; Williams B; Keene BW; Atkins CE; Adin D; Aona B; DeFrancesco T; Tou S; Mackay T
Vet J; 2018 Feb; 232():16-19. PubMed ID: 29428085
[TBL] [Abstract][Full Text] [Related]
18. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
19. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse.
Olsen LH; Kristensen AT; Häggström J; Jensen AL; Klitgaard B; Hansson H; Pedersen HD
J Vet Intern Med; 2001; 15(3):209-16. PubMed ID: 11380029
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels.
Mead SE; Beijerink NJ; O'Brien M; Wade CM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]